Prudence Capital
方圆资本
elsewhere's corpus does not cover Prudence Capital as a subject. The only mention found is a single relation noting it as a co-investor in XtalPi's 2020 funding round alongside Morningside, CICC Capital, Zhaoyin International, and others . No founding date, strategy, team, or fund size appears in the retrieved material.
AI-generated — may contain errors, please verify.
Coverage
DPI > 1 — it's a magic spell.
Before taking responsibility for a new world, GPs must first answer to their LPs.
Source Code Capital Portfolio | Nutshell Therapeutics Announces $40 Million Series A+ Round, Existing Shareholder Source Code Capital Continues to Increase Stake
Advance the conformation-based drug discovery platform and innovative pipeline across all fronts
Allosteric drug discovery company Nutshell Therapeutics has raised $20 million in a Series A round led by Source Code Capital.
Currently the only platform-type allosteric drug discovery company in China driven by computational methods
Morningside-backed XtalPi raises over $300 million in new funding | Light Moments
5Y Capital has long been bullish on the application of computational science in the life sciences, hoping that the convergence of IT and biotechnology will soon usher human health into a new era.
